Search results
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 3 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
I Created a Community For the Chronically Ill. I Didn't Expect It to Save My Life.
PopSugar· 5 days agoOver two decades later, I used my lifetime of experience to build Chronicon, a community and...
13 Times Met Gala Attendees Took "Beauty Is Pain" Way Too Seriously And Wore Looks That Physically...
BuzzFeed via Yahoo News· 2 days agoFor Kim Kardashian, wearing her famous Mugler "wet look" dress was one of the most painful...
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoAbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript April 26, 2024 AbbVie Inc. beats earnings...
Change Eligibility Rules for More Diverse Clinical Trials?
Medscape· 3 days agoExpanding eligibility criteria is a strategy for improving the inclusion of traditionally...
ILD Not Increased With MTX in Patients With Dermatomyositis
Medscape· 4 days agoTreatment with methotrexate was not associated with an increased risk for interstitial lung disease...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 4 days agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 3 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic...
Digital Health Sector Slowed Down in 2023
Medscape· 3 days agoAlthough the average amount raised in European funding rounds decreased, the number of investors increased by nearly one quarter.
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 4 days agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...